Readers hoping to buy Cohen & Steers, Inc. ( NYSE:CNS ) for its dividend will need to make their move shortly, as the... Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under ...

The analysis found that across all the 339 appraisals carried out for the new medicines, the median gain in quality-adjusted ...

Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel Goldlust Access the segment here HOUSTON, TX / ACCESSWIRE / October 10 ...

Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders and Neuraxpharm Group (Neuraxpharm), a leading European ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The global CNS Treatment and Therapy Market is poised for substantial growth, with a projected valuation of USD 123.2 billion by the end of 2023. This market is expected to further expand at a CAGR of ...

If we miss even one of these pillars, we will not be able to achieve TB elimination," added Dr Burhan. And we have to find, treat and prevent TB in a people-centred, rights-based and gender ...

Good morning! Here is today’s summary from Nigerian Newspapers: 1. Reports have emerged that more than 200 suspects who were ...

Background: Matrix metalloproteinases (MMPs) are thought to mediate cellular infiltration in central nervous system (CNS) inflammation by cleaving extracellular matrix proteins associated with the ...